David A. Siegel Jazz Pharmaceuticals PLC Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Two Sigma Advisers, LP holds 81,700 shares of JAZZ stock, worth $11.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
81,700
Previous 106,000
22.92%
Holding current value
$11.5 Million
Previous $11.8 Million
14.84%
% of portfolio
0.02%
Previous 0.03%
Shares
28 transactions
Others Institutions Holding JAZZ
# of Institutions
544Shares Held
59MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$862 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$846 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$355 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$311 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$285 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.79B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...